These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1477 related articles for article (PubMed ID: 7657522)

  • 21. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
    Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
    J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
    Marchetti D
    J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition by sulfated chitin derivatives of invasion through extracellular matrix and enzymatic degradation by metastatic melanoma cells.
    Saiki I; Murata J; Nakajima M; Tokura S; Azuma I
    Cancer Res; 1990 Jun; 50(12):3631-7. PubMed ID: 2340512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells.
    Irimura T; Nakajima M; Nicolson GL
    Biochemistry; 1986 Sep; 25(18):5322-8. PubMed ID: 3768351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Human heparanase: roles in invasion and metastasis of cancer].
    Gohji K; Katsuoka Y; Okamoto M; Kamidono S; Kitazawa S; Toyoshima M; Dong J; Nakajima M
    Hinyokika Kiyo; 2000 Oct; 46(10):757-62. PubMed ID: 11215206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity relationships of heparin-mimicking compounds in induction of bFGF release from extracellular matrix and inhibition of smooth muscle cell proliferation and heparanase activity.
    Benezra M; Ishai-Michaeli R; Ben-Sasson SA; Vlodavsky I
    J Cell Physiol; 2002 Sep; 192(3):276-85. PubMed ID: 12124773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. O-sulfated bacterial polysaccharides with low anticoagulant activity inhibit metastasis.
    Borgenström M; Wärri A; Hiilesvuo K; Käkönen R; Käkönen S; Nissinen L; Pihlavisto M; Marjamäki A; Vlodavsky I; Naggi A; Torri G; Casu B; Veromaa T; Salmivirta M; Elenius K
    Semin Thromb Hemost; 2007 Jul; 33(5):547-56. PubMed ID: 17629853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of heparanase in tumor metastasis and angiogenesis.
    Vlodavsky I; Michaeli RI; Bar-Ner M; Fridman R; Horowitz AT; Fuks Z; Biran S
    Isr J Med Sci; 1988; 24(9-10):464-70. PubMed ID: 2462549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrix.
    Ishai-Michaeli R; Svahn CM; Weber M; Chajek-Shaul T; Korner G; Ekre HP; Vlodavsky I
    Biochemistry; 1992 Feb; 31(7):2080-8. PubMed ID: 1536850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparanase expression in B16 melanoma cells and peripheral blood neutrophils before and after extravasation detected by novel anti-mouse heparanase monoclonal antibodies.
    Komatsu N; Waki M; Sue M; Tokuda C; Kasaoka T; Nakajima M; Higashi N; Irimura T
    J Immunol Methods; 2008 Feb; 331(1-2):82-93. PubMed ID: 18162185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species.
    Bar-Ner M; Eldor A; Wasserman L; Matzner Y; Cohen IR; Fuks Z; Vlodavsky I
    Blood; 1987 Aug; 70(2):551-7. PubMed ID: 2955820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
    Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
    Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
    Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
    Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis.
    Vlodavsky I; Friedmann Y; Elkin M; Aingorn H; Atzmon R; Ishai-Michaeli R; Bitan M; Pappo O; Peretz T; Michal I; Spector L; Pecker I
    Nat Med; 1999 Jul; 5(7):793-802. PubMed ID: 10395325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase.
    Benezra M; Vlodavsky I; Bar-Shavit R
    Exp Cell Res; 1992 Jul; 201(1):208-15. PubMed ID: 1612123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulfated malto-oligosaccharides bind to basic FGF, inhibit endothelial cell proliferation, and disrupt endothelial cell tube formation.
    Foxall C; Wei Z; Schaefer ME; Casabonne M; Fugedi P; Peto C; Castellot JJ; Brandley BK
    J Cell Physiol; 1996 Sep; 168(3):657-67. PubMed ID: 8816920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix.
    Fridman R; Lider O; Naparstek Y; Fuks Z; Vlodavsky I; Cohen IR
    J Cell Physiol; 1987 Jan; 130(1):85-92. PubMed ID: 2433294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity.
    Lider O; Mekori YA; Miller T; Bar-Tana R; Vlodavsky I; Baharav E; Cohen IR; Naparstek Y
    Eur J Immunol; 1990 Mar; 20(3):493-9. PubMed ID: 2318247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
    Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
    Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of polysulfated polysaccharide on experimental encephalomyelitis, proliferation of autoimmune T cells, and inhibition of heparanase activity.
    Hershkoviz R; Mor F; Miao HQ; Vlodavsky I; Lider O
    J Autoimmun; 1995 Oct; 8(5):741-50. PubMed ID: 8579728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 74.